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Abstract 
 
Natural pacing of the heart results in heart rate variability, an indicator of good health 
and cardiac function. A contributor to heart rate variability is respiratory sinus 
arrhythmia or RSA – an intrinsic respiratory modulated pacing of heart rate. The loss 
of RSA is associated with poor cardiac prognosis and sudden cardiac death. We 
tested if reinstatement of respiratory modulated heart rate (RMH) would improve 
cardiac performance in heart failure. Heart failure was induced in Wistar rats by 
ligation of the left anterior descending coronary artery. Rats were unpaced, 
monotonic paced and RMH paced;  the latter had the same average heart rate as 
the monotonic paced animals. Cardiac function was assessed non-invasively using 
echocardiography before and after two weeks of daily pacing at a time when pacing 
was turned off. RMH increased cardiac output by 20 ± 8 % compared to monotonic 
pacing (-3 ± 5 %; P<0.05). This improvement in cardiac output was associated with 
an increase in stroke volume compared to monotonic pacing (P = 0.03) and 
improvement in circumferential strain (P = 0.02).  Improvements in ejection fraction 
(P = 0.08) and surrogate measures of left ventricle compliance did not reach 
significance.  Increases in contractility (P<0.05) and coronary blood flow (P<0.05) 
were seen in vitro during variable pacing to mimic RMH. Thus, in rats with left 
ventricular dysfunction, chronic RMH pacing improved cardiac function through 
improvements in systolic function. As these improvements were made with pacing 
switched off, we propose the novel idea that RMH pacing causes reverse-
remodelling.  
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Introduction 
Respiratory sinus arrhythmia (RSA) is a cardiorespiratory phenomenon 
characterized by an increase in heart rate (HR) during inspiration and a fall during 
expiration (Anrep, Pascual et al. 1936, Eckberg 1983).  From an evolutionary 
standpoint it is highly conserved being found throughout the animal kingdom from 
primitive cartilaginous fish (Taylor 1994). However, despite decades of studies on 
RSA its functional significance remains highly controversial (Larsen, Tzeng et al. 
2010, Ben-Tal, Shamailov et al. 2014).   
Some evidence suggests that RSA equalises cardiac output between the left versus 
the right side of the heart (Elstad 2012). Others have suggested that it optimizes 
pulmonary gas exchange through the close matching of ventilation and pulmonary 
artery blood flow (Hayano, Yasuma et al. 1996, Giardino, Glenny et al. 2003, 
Grossman and Taylor 2007). However, this theory is contentious (Sin, Webber et al. 
2010) and a recent mathematical modelling study could not validate this finding 
(Ben-Tal, Shamailov et al. 2012). Instead, Ben-Tal and colleagues proposed that 
RSA reduced cardiac work while maintaining physiological levels of arterial carbon 
dioxide (Ben-Tal, Shamailov et al. 2014). We suggest that through these 
mechanisms RSA serves to optimize oxygen delivery to the heart with increasing 
workload (Elstad, O'Callaghan et al. 2018).  In contrast, RSA is lost in cardiovascular 
and pulmonary diseases (e.g. heart failure, hypertension and chronic obstructive 
pulmonary disease) but whether this promotes the progression of heart disease is 
unknown. Certainly, a loss of RSA is a well described prognostic indicator for 
cardiovascular disease and sudden cardiac death (Binkley, Nunziata et al. 1991, 
Mortara, La Rovere et al. 1994, La Rovere, Bigger et al. 1998). Thus, in heart failure 
where there is already reduced coronary blood flow and oxygen supply, the absence 
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of RSA may further compromise adequate tissue perfusion enhancing susceptibility 
to episodes of hypoxia triggered by increased metabolic demand (Elstad, 
O'Callaghan et al. 2018) thereby promoting cardiac remodelling (Mulder, Barbier et 
al. 2004). The robust observation of a loss of RSA in cardiorespiratory diseases in 
addition to the predicted role of RSA in enhancing cardiac work efficiency has led to 
the specific question of whether there would be any therapeutic gain from its 
reinstatement in an animal model of heart failure.  
Using a novel analogue biofeedback device, we demonstrated recently that RSA can 
be artificially augmented, at least acutely, by modulating cardiac pacemaker spike 
frequencies in phase with electromyographic activity of the diaphragm in healthy, 
anaesthetised rats (O'Callaghan, Chauhan et al. 2016). Here, we have deployed this 
device to drive RSA chronically in a conscious rat with induced heart failure. We 
tested the hypothesis that enhancing RSA in rats with heart failure will show an 
improvement in cardiac function by ventricular remodelling and that this will be 
superior to that seen with monotonic cardiac pacing. Our novel findings support the 
contention that RSA improves cardiac function in heart failure.  
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Methods 
Ethical Approval 
All animal experiments were performed in accordance with institutional guidelines 
and the UK Home Office (Scientific Procedures) Act (1986) with project approval 
from the respective University of Bristol animal ethics committee.   
Induction of heart failure  
Heart failure was induced by myocardial infarction (MI) in male Wistar rats (280-
300g) according to published methods (Pfeffer, Pfeffer et al. 1979, Francis, Weiss et 
al. 2001). Animals were anesthetized with ketamine (60 mg/kg, i.m.; Vetalar®, 
Boehringer Ingelheim,USA) and medetomidine (250 µg/kg, i.m.; Domitor®, Orion 
Pharma, UK), endotracheally intubated (after local swab application of 2% 
Xylocaine® HCl (AstraZeneca, UK)), and ventilated mechanically (70-85 breaths per 
minute, 1.5-2.0mL/breath; Advanced Safety Ventilator MA1 55-7059, Harvard 
Apparatus, USA). A left thoracotomy at the 4th intercostal space was performed to 
expose the heart, and the left anterior descending coronary artery was ligated with 
polyester suture (4-0) between the pulmonary artery outflow tract and the left atrium.  
The thoracotomy was closed with suture and the rats recovered with atipamezole 
(2mg/kg s.c.; Antisedan®, Pfizer, USA), given Buprenorphine (30µg/kg i.m. 
Vetergesic®, CeVa, UK) for analgesia and Hartman’s solution for rehydration as 
required.  Approximately 7 days post- MI, rats were re-anaesthetised with isoflurane 
(5% induction, 1.8-2.0% maintenance via a nose cone) and the cardiac function was 
assessed using non-invasive echocardiography (see below) to select rats with a 
sufficient infarct. 
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Surgical implantation of EMG, ECG and pacing leads.  
Rats with an ejection fraction ≤50% measured one week after MI were selected to 
undergo the second surgery for implantation of cardiac pacing and dEMG recording 
leads. A 6-channel pedestal with back-mount (Type 363 components, PlasticsOne, 
USA) contained percutaneous electrodes (2× cardiac ECG, 2× dEMG and 2× cardiac 
pacing) and remained externalised for tethering. Electrodes had socket-pin 
connections at the pedestal and stainless-steel suture-pads (~0.5mm2) for electrical 
recording/stimulation (PlasticsOne, USA).  For implantation, rats were anesthetized 
and mechanically ventilated as described above.  Using aseptic techniques, the 
sterilised multi-lead electrode pedestal was sutured into place (nylon monofilament, 
4-0, Ethilon, Ethicon®, USA) between the scapulae. The chest was opened on the 
right side between the 3rd and 4th intercostal space, the lungs retracted and the two 
cardiac pacing leads anchored at two positions using sutures (6-0 TiCron™ Braided 
Polyester Suture, Covidien, USA): (i) 2-3 mm from the electrode pads the leads were 
secured to the right ventricle via a small tear in the pericardium at an endocardial 
depth ≤0.5mm. (ii) pacing electrodes were sutured separately to the right atrium, 
maintaining an inter-electrode distance of 1-2mm.  The electrode suture pads 
(contacts) were in direct contact with the myocardium.  The 3rd intercostal space was 
closed with 3-4 sutures (4-0, Mersilk braided, Ethicon, USA).  The leads exited the 
chest through the 4th intercostal space which was closed using a purse-string suture 
immediately after restoring negative intra-pleural pressure and spontaneous 
breathing restored.  The leads were anchored extra-thoracically with suture to the 4th 
intercostal space. The two ECG leads were sutured (4-0, Mersilk braided, Ethicon, 
USA) via their suture pads subcutaneously at the 1st or 2nd intercostal space and the 
second at the xyphoid process. Finally, the recording leads were posted through an 
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incision in the abdominal muscle layer posterior to the last rib and sutured (4-0, 
Mersilk braided, Ethicon, USA) to the right-lateral costal diaphragm, as previously 
described (O'Callaghan, Chauhan et al. 2016).  The abdominal muscular wall was 
closed and the overlying skin incision closed with sutures. All leads were tunnelled to 
the pedestal and connected to it. Prophylactic antibiotics (s.c, 2% Baytril®, Bayer 
Animal Health, UK), analgesics (s.c. Buprenorphine) and hydration solution 
(Hartman’s solution i.p) were given to aid post-operative recovery. Atipamezole (s.c) 
was given to reverse anaesthesia and the rats were recovered under a heat lamp 
until mobile.  Post-operative care was given according to veterinary guidelines and 
rats regained pre-operative body weight within 2-5 days.  Rats were recovered for 2-
3 weeks before experimental pacing was initiated.   
Approximately 10 animals died between LAD ligation and the end of the study and all 
deaths occurred during or within 24 hours of this second surgery.  A similar mortality 
rate from this surgery occurred in SHAM-MI rats in an earlier pilot study, indicative of 
a high-risk surgery. 
Pacing protocol 
Three to four days before the pacing protocol was initiated, rats were acclimatised to 
the tethering setup.  During acclimatisation, dEMG and ECG were recorded (1401 
acquisition hardware and Spike2 v8 software, Cambridge Electronic Design, UK) 
after amplification (both ×10k gain, 300-500Hz filtered; Model 1700 Differential AC 
Amplifier, A-M systems, USA) and the average resting heart was determined from 
their ECG.  The pacing threshold was determined in each rat by recording an ECG 
whilst stimulating the right atrial electrodes at 450 bpm (Hz) and increasing the 
voltage until the rat heart beat was reliably paced (1.2 - 3.9 V).  The heartbeat was 
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deemed paced when the QRS complex had a physiological latency from the stimulus 
artefact (or artificial P wave) of 55-65 ms.   
At 4 weeks post-MI, pre-pacing cardiac function was assessed by echocardiography 
(described below).  The following day daily pacing commenced (8 hours per day for 
two weeks) and set above their intrinsic HR at rest.  Rats were divided into three 
groups: (i) respiratory-modulated heart rate paced (RMH; n=5) using our previously 
described biofeedback device (Nogaret, Zhao et al. 2013, O'Callaghan, Chauhan et 
al. 2016); (ii) monotonically paced (n=5) with an isolated, constant voltage stimulator 
(DS2A, Digitimer Ltd, UK) triggered by a TTL output generated by a digital-analogue 
converter output, controlled by Spike2 software; (iii) unpaced (n=7) for a  time-
matched control. The RMH waveform was tuned at the start of day 1 such that the 
minimum HR was above the average intrinsic HR at rest and the peak-trough 
amplitude of RMH was 20-30 bpm, with peak HR occurring with inspiration (Figure 
1B, inset). The HR of the monotonic group was matched to the average HR of RMH-
paced rats (Figure 1B, inset).  Rats were paced as described for 14 days and no 
animals died during the pacing (or unpaced) protocol period.   
The percentage of successful pacing was determined daily using a bespoke software 
code (Spike2, CED, UK) that enabled R-waves from the ECG recording to be 
counted from a post-stimulus triggered histogram triggered by the pacing voltage 
artefact (Figure 1C).  The efficacy of pacing was calculated and based on the 
number of R-waves within 55-65 ms of the stimulus artefact relative to the total 
number of paced stimuli and multiplied by the duration of pacing to get a daily pacing 
efficacy. This was averaged over the 14 days of pacing and we set the average 
pacing efficacy cut off at 30 %, below which rats were excluded.  This cut-off yielded 
the most similar amount of pacing between the monotonic and RMH paced groups.  
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Echocardiography 
Analysis of cardiac function was conducted non-invasively using start of the art 
echocardiography and previously established methods (MKT02620 Imaging Guide, 
FUJIFILM VisualSonics Inc, The Netherlands)(Baily, Lehman et al. 1993, Lang, 
Bierig et al. 2005).  Echocardiography was conducted at two time-points, on all 
animals under isoflurane anaesthesia (1.8%) while the pacing was off: (i) the day 
before pacing was initiated and (ii) the day after the 14th day of pacing. With pacing 
off we could fully test the hypothesis that RMH pacing improved cardiac function 
through therapeutic remodelling. Both motion (M)-mode and brightness (B)-mode 
views of the parasternal short axis (PSAX) and parasternal long axis (PSLAX) were 
taken in duplicate.  B-mode, PSAX views were taken at 3 transverse locations, 2-3 
mm posterior to the base, mid-papillary and 2-3 mm anterior to the apex of the heart.  
These 3 locations and the long-axis length (aortic valve to endocardial apex) were 
used for the Simpson’s method of calculating end-diastolic and end-systolic LV 
volumes from which other cardiac function variables were calculated automatically 
by the software (Vevo LAB v3.1.0, FUJIFILM VisualSonics Inc, The Netherlands).  
These included cardiac output, ejection fraction, fractional area shortening and 
stroke volume.  Heart rate was calculated from the RR interval on the concurrently 
recorded ECG waveform. The cardiac function variables of the PSAX views of the 
base, middle and apex were averaged for each rat and the values before and after 2 
weeks of pacing (and 2 weeks unpaced) were compared and grouped.  LV posterior 
wall diameters were calculated from the PSAX (B-mode), mid-papillary view (Figure 
4A).  Echocardiography analysis was not blinded but was repeated 3 months after 
the first analysis and raw data results were within the 3-9 % expected intra-user 
variability range (Stein, Tiwari et al. 2007) and the outcomes of grouped average 
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comparisons were consistent between both rounds of analysis. Data from the 
second round of analysis was used for statistical analysis and reporting. 
Cardiac strain analysis (Speckle-tracking echocardiography)   
Changes in cardiac strain have previously been reported as occurring early in the 
cardiac remodelling process in mouse models of myocardial infarction (Yamada, 
Arrell et al. 2013, Bhan, Sirker et al. 2014).  Therefore, VisualSonics VevoStrain 
software was used on images previously acquired using echocardiography to assess 
the effect of the pacing paradigms on cardiac contractility using established methods 
(Bhan, Sirker et al. 2014, Pedrizzetti, Mangual et al. 2014, Kovács, Oláh et al. 2015).  
B-mode images of the PSAX views over 3 consecutive heart beats during expiration, 
at 3 transverse locations (base, middle, apex) were analysed using the VevoStrain 
software, before and after two weeks of pacing.  Endocardial walls were traced and 
the software algorithms automatically calculated radial and circumferential peak 
strain (expressed as % thickness relative to its original length), where increased 
contractility means more positive radial strain and more negative circumferential 
strain (Dandel, Lehmkuhl et al. 2009, Bhan, Sirker et al. 2014).  Each transverse 
section was divided into 6 equal segments (Figure 3A) and the data grouped to 
include the anterior free wall, lateral wall, posterior wall and inferior free wall.  The 
posterior septal wall and anterior septum were excluded from analysis because they 
were obscured by the sternum to a variable degree in different rats.  The anterior 
free and lateral walls were predominantly infarcted whilst the posterior and inferior 
free walls were non-infarcted. 
B-mode images of the PSLAX were also analysed using VeVoStrain software to 
calculate peak radial and longitudinal strain, strain rate and time to peak strain 
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(TTP).  The standard deviation of TTP strain was calculated as a measure of cardiac 
dyssynchrony (Yamada, Arrell et al. 2013). 
Histological analyses 
After the final echocardiography measurements rats were deeply anaesthetised with 
sodium pentobarbital (200 mg/kg i.p.) and perfused retrogradely via the ascending 
aorta with isotonic saline supplemented with 0.2M KCl to arrest the heart in diastole, 
followed by fixation with 4% paraformaldehyde in phosphate buffered saline.  The 
heart was excised, stored in fixative for 2 hours (4 °C) and then 30% sucrose in 
phosphate buffered saline overnight.  The tissue was cut coronally into 4 equal 
segments and each segment was paraffin embedded and cut at 7µm thickness onto 
gelatin-coated slides.  Alternate sections were stained with Masson’s Trichrome and 
Picrosirius Red and infarct size calculated from an average of 12 sections per animal 
using planimetry and public-domain software (NIH ImageJ, USA).  The perimeter 
length of the infarcted myocardium was expressed as a percentage of the total left 
ventricle circumference.  Collagen infiltration was quantified from picrosirius red 
stained sections (20 images per rat) using polarised light according to standard 
methods.  Two polarising filters were used to cause birefringence of collagen fibres 
to distinguish type I and III collagen and photographed (Leica DM750 microscope 
with Leica Hi Plan 40x objective and a ICC50W camera).  Collagen fibres, appearing 
green and orange under polarised light were quantified using public-domain software 
(NIH ImageJ, USA) and expressed as the percentage of total myocardial area per 
section. 
Spectral analysis 
ECG recordings were made in each treatment group while rats were tethered and 
resting on day 0 before pacing and day 14 after pacing, while pacing was switched 
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off.  Segments of ECG data were imported into LabChart (version 7, ADInstruments, 
AUS) at 1kHz and 5min periods of stable heart rates were analysed with the in-built 
HRV software according to standard settings for rat: 150 ms < normal RR interval 
range < 218 (ectopic beats excluded), 1 ms histogram bin size, variation threshold 
(deltaNN) >16 ms, 512 FFT, Hann window, 1/2 overlap and frequency bands: VLF 0-
0.27 Hz, LF 0.27-0.75 Hz, HF 0.75-3.3Hz (Waki, Katahira et al. 2006).  
Langendorff preparation to investigate coronary flow and LV contractility  
The effects of RMH versus monotonic heart rates on coronary flow and LV 
contractility were evaluated in Langendorff heart preparations. Male Wistar rats (280-
300g; n = 7) were anesthetized with isoflurane (5%) and the heart was quickly 
removed and immersed into ice cold Krebs-Henseleit buffer containing (mM): 118 
NaCl, 25 NaHCO3, 4.8 KCl, 1.2 KH2PO4, 1.2 MgSO4, 1.2 CaCl2, 11 glucose and 95% 
O2 and 5% CO2 at 37 °C (pH 7.4). After aortic cannulation, the heart was perfused 
with constant pressure (70-80 mmHg) and coronary flow measured by collecting the 
effluent. Coronary perfusion pressure was measured through a side branch of the 
perfusion cannula connected to a pressure transducer (ADInstruments, AUS). The 
left ventricular pressure was measured with a water-filled balloon inserted into the 
left ventricle and connected to a second pressure transducer. The balloon volume 
was modified through a stopcock attached to the ventricular pressure transducer 
using a syringe to maintain a left ventricular diastolic pressure of 5–10 mmHg. 
Coronary perfusion and ventricular pressure signals were recorded using Power 
Lab/4SP acquisition hardware and LabChart software (both ADInstruments, AUS). 
HR and left ventricular contractility (+dP/dt - maximal slope of the systolic pressure 
increment) were calculated from the ventricular pressure pulses. Bipolar electrodes 
were placed into the right atrium for electrical stimulation of the sinoatrial node. 
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Pacing was produced by an isolated constant voltage stimulator (DS2A, Digitimer 
Ltd, UK) coupled to a computer and the software Spike 2 (Cambridge Electronic 
Design, UK) which was used to control the stimulation. Two patterns of stimulation 
were performed on each heart; monotonic and simulated RMH.  The simulated RMH 
had a duty cycle of 0.4s high-HR and 0.6s low-HR, where the low HR was 10bpm 
above baseline and the high HR was 30-50bpm above the low HR. Monotonic 
pacing was the average of the low and high HR.  Stimulus pulses were 1 ms wide 
and 3-5V amplitude. The stimulations were performed under β-adrenergic receptor 
blockade, atenolol (15mM), to avoid sympathetic stimulation. The blockade 
effectiveness was tested by isoproterenol (20nM). Pacing was performed 20-40 min 
after left anterior descending coronary artery occlusion. At the end of the experiment, 
the hearts were perfused with Evans’ blue to allow quantification of the infarct size. 
Statistical analysis 
Paced HR and pacing efficiency were compared with a student’s t test and 95% 
confidence interval where α = 0.05.  Changes in cardiac function were assessed by 
first normalising the value in each rat after two-weeks of treatment to the value 
before treatment.  Normalised values were averaged within treatment groups and a 
one-sample t test (hypothetical mean = 0, α = 0.05) was used to test for a difference 
to null effect. Between group differences were first assessed using a one-way 
ANCOVA, where change was the dependent variable and baseline the covariate.  If 
the covariate was not the source of variation, a one-way ANOVA followed by post 
hoc Bonferroni’s t test for multiple comparisons was used to compare data between 
groups.   
The effect size and 95% confidence intervals of each treatment on the measures of 
cardiac function was calculated using Cohen’s d method (Cohen 1988) to assess the 
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magnitude of mean difference in cardiac function with treatment.  An effect size of 
0.2, 0.4 and 0.8 are considered small, medium and large changes in magnitude 
respectively (Cohen 1988).  
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Results 
Exclusion criteria and group numbers 
37 rats with MI were studied.  Prior to the first day of pacing, sensing from the right-
atrial pacing leads was used to record the electrical activity at the right atrial pacing 
lead site to infer the presence/absence of atrial contact.  Rats in which atrial contact 
was poor and insufficient for atrial pacing formed the unpaced group (n=7). Rats in 
the pacing groups that were successfully paced for < 30% of the daily pacing 
duration (averaged over 14 days) were excluded (n=6).  Rats with an infarct size 
<30%, determined histologically, were also excluded from further analysis (n=12).  
Thus, 19 rats completed the study comprising 7 unpaced, 6 RMH- and 6 
monotonically- paced.   
Efficacy of pacing and its variation in the RMH group 
The resting HR of conscious rats before pacing was 343 ± 7 bpm and 333 ± 8 bpm 
for the monotonic and RMH groups respectively.  Therefore, rats were paced above 
this rate to ensure most of the pacing duration was above intrinsic HR.  The daily 
duration of effective pacing was not significantly different for monotonic- (44% 
effective, 2.7 ± 0.2 hours) versus RMH (50% effective, 3.5 ± 0.6 hours) paced rats 
(P=0.31).  The mean paced HR was not different between monotonic- and RMH- 
paced groups (396 ± 6 bpm and 399 ± 7 bpm respectively, P=0.90).  As expected, 
the within-rat standard deviation of paced HR (i.e. its variance) was different 
between monotonic- and RMH- paced groups (0 ± 0 bpm and 15 ± 2 bpm 
respectively, P = 0.0001).   
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Improvement in cardiac function after RMH pacing 
Both prior to pacing being initiated and at the end of the 2-week pacing period, data 
were obtained by echocardiography in anaesthetised rats with pacing switched off.  
These data for each treatment group are shown in Table 1.  With pacing off, intrinsic 
HR during echocardiography at the end of 2 weeks pacing were: 407 ± 9 bpm for 
unpaced, 381 ± 11 bpm for monotonic and 411 ± 9 bpm for RMH; these were not 
different.  In the RMH group cardiac output was greater than that in the monotonic 
paced rats (23 ± 6 % vs. -3 ± 5 %;Figure 2A, P<0.05).  The cardiac index, which 
corrects for differences in body weight, was numerically (but not statistically) higher 
in RMH versus monotonic paced rats (Figure 2A, P = 0.05). RMH paced rats had a 
significant increase in cardiac output (P=0.03) but not cardiac index (P=0.17) when 
compared to pre-pacing treatment values (Paired T-test).  In monotonic paced rats, 
the cardiac and stroke volume indices were decreased compared to their baseline 
values (-12 ± 4 % and -13 ± 5 % respectively, P< 0.05).  
Further interrogation of cardiac function indicated that the relative increase in cardiac 
output observed after 2 weeks RMH vs monotonic pacing was more likely due to an 
numeric increase in stroke volume (25 ± 8 % vs. -5 ± 5 %; Figure 2B) and not heart 
rate, as HR was not different between treatment arms (Figure 2C).  However, 
statistical analysis of stroke volume (using ANCOVA) suggested that the baseline 
value contributed to the source of variation (P = 0.03) and therefore between-group 
comparisons would not be appropriate for this variable.  All measured cardiac 
variables were tested using the ANCOVA model to identify any interactions with 
baseline values that may have contributed to differences between RMH- and 
monotonic- paced rats.  The results are shown in table 2.  The relative increase in 
stroke volume of RMH vs monotonic paced rats likely reflects a difference in ejection 
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fraction (11 ± 6 % vs. -9 ± 7 %, P = 0.09; Figure 2D) since left ventricular end-
diastolic volume (LVEDV) did not change in RMH vs monotonic-paced rats after 2 
weeks of pacing (Figure 2E).  Ejection fraction and LVEDV were not different in 
RMH- or monotonic- paced rats when compared to unpaced rats.  The cardiac 
function data collected before and after 2 weeks, averaged within treatment groups, 
is shown in Table 1.     
Whilst RMH did not induce a statistically significant difference in ejection fraction and 
LVEDV (within groups), an examination of the effect size of RMH and monotonic 
pacing on the mean difference in these variables (shown underneath the respective 
columns in Figure 2) suggests that RMH pacing had a moderate positive effect on 
ejection fraction (effect size 0.35) where monotonic pacing had a moderate negative 
effect (effects size -0.32).  RMH pacing also had a moderate-strong, positive effect 
on LVEDV (effect size 0.77).  The mean difference over time of each cardiac 
variable, averaged within treatment groups and calculated effect sizes with 
confidence intervals are given in supplementary table 1.   
Chronotropic analysis 
There was no difference in resting basal HR (whilst pacing was off) between the 3 
groups before or after 2 weeks of pacing treatment as recorded under anaesthesia 
(Two-way ANOVA with replication, P > 0.05, n = 10, data not shown). Thus, HR did 
not change after 2 weeks of pacing (or unpaced) in any group.  Spectral analysis of 
the R-R interval showed no change within or between groups in the LF, HF 
oscillations or LF: HF ratio after 2 weeks of pacing (data not shown).  This suggests 
pacing had no effect on parasympathetic cardiac tone or cardiac autonomic balance 
over 2 weeks of pacing (or unpaced).  
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Potential mechanisms for the improvement in cardiac function with pacing 
 (i) Systolic function  
Systolic function was assessed using myocardial wall strain analysis.  
Circumferential strain became more negative after 2 weeks of RMH pacing, 
indicating improved circumferential contractility in this group (-33 ± 9%, P = 0.01 
compared to null effect; Figure 3C). There was no change in circumferential or radial 
strain within the unpaced or monotonic- paced treatment groups (compared to null 
effect).  There was no difference in radial or circumferential short axis strain between 
treatment groups (Figure 3C).  There were no differences within or between groups 
in the improvement (or decline) in cardiac dyssynchrony (time to peak strain (T2P)) 
or in global longitudinal strain or strain rates (Figure 4D-F). 
 (ii) Diastolic function 
LVED posterior wall (LVEDPW) thickness (indicated in Figure 5A) is strongly 
correlated with myocardial wall stiffness and can be used in the absence of LVED 
pressure (LVEDP) data to estimate diastolic function (Grossman, McLaurin et al. 
1974).  LVEDPW thickness during diastole, measured using echocardiography, 
tended to increase after 2 weeks in the unpaced group (1.82 ± 0.09 mm vs 1.95 ± 
0.03 mm, P=0.11), but was unchanged after 2 weeks of RMH- (1.95 ± 0.12 mm vs 
1.82 ± 0.07 mm, P=0.12) or monotonic- (1.81 ± 0.09mm vs 1.84 ± 0.13mm, P=0.34) 
pacing.  There was no difference in effect of treatment groups on LVEDPW thickness 
(Figure 5B).  The proportion of collagen in the myocardium, determined 
histologically, was not different between the three groups after 2 weeks of pacing 
(unpaced, 5.3 ± 0.8%, n = 4; monotonic, 5.3 ± 0.9%, n = 4; RMH, 5.1 ± 0.8%, n = 5; 
Figure 5E), suggesting no detectable reduction in fibrosis from either pacing 
paradigms over this time frame. 
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Coronary flow and LV contractility analysis  
The effects of RMH on coronary flow and LV contractility was evaluated in isolated 
hearts before and after MI. In vitro, the left anterior descending coronary artery 
occlusion produced an extensive MI (55 ± 3%, Figure 6B).  Acute simulated RMH 
pacing increased coronary flow (10 ± 3%), LV contractility (dP/dtmax 8 ± 3%) and LV 
relaxation (dP/dtmin 11 ± 4%)).  Monotonic pacing increased coronary flow (14 ± 3%), 
dP/dtmax (9 ± 2%) and dP/dtmin (11 ± 4%) to the same magnitude as simulated RMH 
(Figure 6A, C - E).   
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Discussion 
The major finding of the present study indicates that, for the primary comparison, 
RMH increased cardiac output compared to monotonic-pacing in rats with heart 
failure after two weeks of pacing. Further, the improvement in cardiac output 
observed after 2 weeks of RMH pacing was with pacing switched off.  Given this, we 
suggest that the improvement in cardiac output reflects a process of reverse-
remodelling in rats with left ventricular dysfunction.  
There is an abundance of evidence demonstrating RSA is diminished or absent in a 
range of chronic diseases, including cardiovascular disease and heart failure.  
However, the function of this physiological phenomenon is yet to be fully established.  
The proposed benefits of RSA include stabilisation of blood pressure, optimisation of 
cardiopulmonary gas exchange and increased cardiac energy efficiency (Hayano, 
Yasuma et al. 1996, Giardino, Glenny et al. 2003, Elstad 2012, Ben-Tal, Shamailov 
et al. 2014). Any one of these would assist patients with heart failure where 
myocardial function and energy are suboptimal.  In addition, existing pacemakers do 
not apply within-breath modulation of heart rate and therefore, are more like the 
monotonic treated rat group in this study.  Until now it was not possible to chronically 
reinstate RSA and investigate its potential therapeutic effects in a conscious animal 
with heart failure.  This study is the first to have used a novel pacemaker with 
physiological biofeedback to investigate if reinstating RMH improves cardiac function 
in rats with left ventricular dysfunction beyond that achieved with conventional, 
monotonic pacing.   
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Caveats 
Both monotonic and RMH pacing captured the heart rate for an equivalent amount of 
time each day that was less than the full duration of the tethered pacing period (44 
and 53% for monotonic and RMH respectively). This was in most part due to 
intermittent grooming, eating and sniffing behaviour of the rat that drove heart rate 
above the pacemaker set point.  This resulted in rats being actively paced for only 
~3-4 hours each day, a relatively short duration compared with patients paced in 
clinical practice.  However, it is thought that the process of cardiac remodelling is 
similar in process but occurs more rapidly in rats than in humans (Goldman and 
Raya 1995, Cleutjens, Blankesteijn et al. 1999).  In addition, a novel study 
demonstrated that 6 hours a day of pacemaker-induced asynchrony in canines with 
heart failure resulted in significant improvements in cardiac function (Kirk, Chakir et 
al. 2015).  
As demonstrated in our previous study, the RMH waveform was consistent with the 
RSA waveform reported in conscious, healthy rats (Bouairi, Neff et al. 2004), 
whereby HR increased during inspiration and decreased during expiration 
(O'Callaghan, Chauhan et al. 2016).  We did not investigate the long-term effect of 
pacing with different waveform patterns, such as inverse RSA or non-respiratory 
frequencies of heart modulation; and this awaits future investigations. 
The relative increase in cardiac output observed in this study was driven by an 
increase in stroke volume without a change in heart rate.  Stroke volume can be 
increased by an elevation in ejection fraction where LVEDV is maintained (increased 
contractility) or by enhanced filling where ejection fraction is maintained.  The latter is 
caused by increased diastolic capacity arising from better myocardial compliance.  In 
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this study, whilst the increase in ejection fraction did not reach significance in RMH-
paced rats, there was a moderate, positive effect size of RMH on ejection fraction.  
In monotonic-paced rats, ejection fraction did not reach a significant change from 
baseline, but there was a moderate effect size of monotonic pacing with lower 
ejection fraction.  Taken together, this suggests there was a tendency for RMH 
pacing to increase the ejection fraction compared to monotonic pacing.  In addition, 
circumferential peak strain was significantly improved by RMH pacing suggesting an 
improvement in contractility of the recovering myocardium.  Since circumferential 
peak strain is negatively associated with MI severity (Bhan, Sirker et al. 2014), the 
latter finding supports the notion that RMH pacing reverses the pathological 
remodelling in heart failure.  However, these results were not found consistently with 
other measures of cardiac strain analysis and a larger cohort of rats is likely required 
to address this.   
RMH pacing may have also prevented deterioration in diastolic function in rats with 
left ventricular MI.  It is known that myocardial compliance decreases over time in the 
rat model used herein because of increased interstitial collagen infiltration 
(Whittaker, Kloner et al. 1994, Milanez, Gomes et al. 1997).  Whilst it was not 
technically possible to measure LVEDP in our rats in the conscious state, we did 
measure LVEDPW thickness and observed a decrease in the unpaced rats, 
suggesting worsening compliance over the 2-week period (i.e. weeks 4 to 6 post-MI).  
However, in the RMH paced rats, LVEDPW was thicker suggesting the decline in 
compliance was stalled.  In addition, whilst LVEDV was not significantly increased in 
RMH or decreased in monotonic groups, there was a moderate to large effect size of 
RMH increasing LVEDV.  However, there was no difference in interstitial collagen 
infiltration, suggesting that any improvement in LV myocardial compliance is unlikely 
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to have driven the increased cardiac output in RMH-paced rats. On balance, the 
relative increase in cardiac output could be due to the synergistic interaction 
between subtle improvements in both diastolic and systolic function. However, the 
evidence to date points in favour of improving systolic function driving the therapeutic 
benefit of RMH compared to monotonic pacing.  Further studies are required to 
determine the longevity of the RMH-induced increase in cardiac function after pacing 
is withdrawn. 
Novel insights into the function of RSA 
Recent mathematical modelling of RSA suggested it could conserve cardiac energy 
whilst maintaining PaCO2 (Ben-Tal, Shamailov et al. 2012).  Improved cardiac 
efficiency is contingent on decreased myocardial oxygen demand and this could be 
achieved by either optimisation of coronary blood flow and/or intracellular calcium 
bioavailability.  Coronary blood flow is decreased in experimental heart failure and 
cannot match demand (Spinale, Tanaka et al. 1992).  Because it is not technically 
possible to measure coronary artery flow in real time in conscious rats, we paced 
isolated perfused in vitro working hearts. RMH increased coronary flow before and 
after MI to the same extent as monotonic pacing, and this correlated to heart rate 
reflecting an intrinsic matching of blood flow to work load. Similarly, LV contractility 
was increased during both RMH and monotonic pacing after MI.  There is known to 
be a dynamic relationship between intracellular calcium transients and the preceding 
diastolic duration in isolated cardiomyocytes (Frampton, Orchard et al. 1991); 
however, the summative effect on cardiomyocyte contractility from pacing multiple, 
successive contractions with inter-beat variability versus a monotonic protocol is less 
clear.  One study in rats demonstrated that pacing isolated cardiac trabeculae at an 
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average of 8Hz with a 40% variation in inter-beat interval generated 10% greater 
contractile strength than when pacing at the same average frequency without inter-
beat variability (Torres, Varian et al. 2008).  Interestingly, this effect was not 
observed at lower frequencies (4Hz or 6 Hz) in the same study and in another study, 
using the same protocol on cardiac trabeculae isolated from rabbit and canine; no 
difference was observed between monotonic and variable inter-beat interval pacing 
at the same average frequency in either species (Torres and Janssen 2011).  It is 
worth noting that the variability employed in these studies was random, and thus 
more relevant to a situation of pathological arrhythmia than a physiological rhythm 
such as RMH.   
Despite the beneficial effects achieved with RMH in vitro, we acknowledge that the 
isolated perfused heart lacks: (i) central autonomic innervation which, in part, has 
respiratory modulated activity (McAllen and Spyer 1978, Boscan, Allen et al. 2001) 
and contains vasodilatory vagal fibres innervating the coronary circulation (Feigl 
1983), which may be important in increasing coronary blood flow on a breath by 
breath basis; and (ii) respiratory phasic changes in both intra-thoracic pressure and 
venous return which may both function to enhance coronary blood flow and increase 
pre-load for optimal cardiac filling; the latter would engage the Starling mechanism to 
increase contractility. These physiological mechanisms may all contribute to the 
beneficial effects of RMH versus monotonic pacing. Given this, we propose that 
future studies be conducted in conscious large animal models in vivo where coronary 
flow and left ventricular pressure can be measured in real time chronically with the 
different pacing paradigms. This would also allow an assessment of whether 
additional benefit can be obtained by pacing for longer than two weeks.  
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Another technique to investigate whether RMH pacing improved myocardial function 
may have been to measure oxygen levels within a coronary artery.  This is not 
feasible in small animals, however arterial oxygenation from a femoral artery can be 
used.  Whilst we did not measure arterial blood gases in the rats in this study, we did 
measure arterial blood gases in an earlier pilot study.  In the pilot study, peripheral 
blood gases were measured before and after 45 min of RMH and monotonic pacing 
in anaesthetised rats 2 weeks post-LAD ligation and we found no difference in PaO2 
or PaCO2 with either treatment (E. O’Callaghan, R. Lataro, JFR Paton – unpublished 
findings). However, this could have been confounded by anaesthesia and/or 
relatively short duration of pacing.  Future studies in a larger animal model are 
required to adequately address this question. 
Clinical relevance  
In the UK alone, over 31,000 pacemakers are implanted per year to alleviate the 
symptoms of sinus node disease or AV block (Brignole, Auricchio et al. 2013, 
Edwards, Karner et al. 2015).  All pacemakers function monotonically and some 
increase heart rate over successive breaths in response to the detection of 
increased movement or minute ventilation (Coman, Freedman et al. 2008).  Existing 
pacemakers are unable to apply within-breath modulation of heart rate such as 
RMH.  To date, no clinical trial has investigated whether cardiac function is 
compromised by the monotonic nature of existing cardiac pacemakers.  There is, 
however, substantial evidence demonstrating that persistent ventricular asynchrony 
within cardiac contractions, caused by single-chamber cardiac pacing, is associated 
with a decline in ejection fraction and development of cardiomyopathy (Khurshid, 
Epstein et al. 2014, Bellmann, Muntean et al. 2016) and increased hospitalisations 
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for heart failure (Sweeney and Hellkamp 2006).  Cardiac resynchronisation therapy, 
whereby left and right ventricles are paced in synchrony, aims to better emulate a 
physiological cardiac contraction and has demonstrated success in reversing the 
single-chamber pacing-induced cardiomyopathy (Eldadah, Rosen et al. 2006, 
Leclercq, Cazeau et al. 2007, Bellmann, Muntean et al. 2016, Khurshid, Obeng-
Gyimah et al. 2018).  Interestingly, it has been observed in a clinical setting, that the 
functional improvements driven by CRT are more pronounced in individuals starting 
with asynchronous heart failure (Kirk and Kass 2013), suggesting the restoration of 
synchrony has stronger biological effects than continuation of synchrony in heart 
failure.  This phenomenon has since been demonstrated a canine model of heart 
failure (Kirk, Chakir et al. 2015) and raises the question in this study; is it the bouts of 
variability that are driving the observed changes in cardiac function?  In this study, 
we observed that 2 weeks of monotonic pacing decreased cardiac and stroke 
volume indices, suggesting monotonic pacing was detrimental to cardiac function.  
The underlying mechanism for this effect needs further investigation as we were 
unable to demonstrate significant changes in the measures of diastolic or systolic 
function that were possible in this study.   
Conclusion 
We observed an increase in cardiac output in rats with left ventricular diastolic 
function after 2 weeks of pacing with a RMH but not with a conventional monotonic 
paradigm.  The precise mechanism behind our novel observation requires further 
elucidation in fully instrumented large animals. However, the results presented 
herein are a tantalising demonstration of the physiological relevance of RSA. 
 
26 
 
Acknowledgements/author contributions 
Dr S. Bryant for assistance with echocardiography training and Dr W. Pijacka for 
technical assistance.  Prof S. Suleiman for access to Langendorff preparation 
equipment.  FUJIFILM VisualSonics Inc., The Netherlands, for technical support for 
echocardiography training.  Cambridge Electronic Design for bespoke design of 
Spike2 software scripts for automated ECG analysis. 
 
Sources of Funding 
Financial support from the BHF (NH/14/1/30761 and RG/12/6/29670) and the EU 
(Horizon 2020 CRESPACE Grant No. 732170).  
 
Disclosures 
The authors have no conflicts of interest to declare. 
 
27 
 
References 
Anrep, G. V., W. Pascual and R. Rossler (1936). "Respiratory variations of the heart 
rate II - The central mechanism of the respiratory arrhythmia and the inter-relations 
between the central and the reflex mechanisms." Proceedings of the Royal Society 
Series B-Biological Sciences 119(813): 218-U216. 
 
Baily, R. G., J. C. Lehman, S. S. Gubin and T. I. Musch (1993). "Non-invasive 
assessment of ventricular damage in rats with myocardial infarction." Cardiovasc 
Res 27(5): 851-855. 
 
Bellmann, B., B. G. Muntean, T. Lin, C. Gemein, K. Schmitz and P. Schauerte 
(2016). "Late deterioration of left ventricular function after right ventricular pacemaker 
implantation." Anatol J Cardiol 16(9): 678-683. 
 
Ben-Tal, A., S. S. Shamailov and J. F. Paton (2012). "Evaluating the physiological 
significance of respiratory sinus arrhythmia: looking beyond ventilation-perfusion 
efficiency." J Physiol 590(Pt 8): 1989-2008. 
 
Ben-Tal, A., S. S. Shamailov and J. F. Paton (2014). "Central regulation of heart rate 
and the appearance of respiratory sinus arrhythmia: new insights from mathematical 
modeling." Math Biosci 255: 71-82. 
 
Bhan, A., A. Sirker, J. Zhang, A. Protti, N. Catibog, W. Driver, R. Botnar, M. J. 
Monaghan and A. M. Shah (2014). "High-frequency speckle tracking 
echocardiography in the assessment of left ventricular function and remodeling after 
murine myocardial infarction." Am J Physiol Heart Circ Physiol 306(9): H1371-1383. 
 
Binkley, P. F., E. Nunziata, G. J. Haas, S. D. Nelson and R. J. Cody (1991). 
"Parasympathetic withdrawal is an integral component of autonomic imbalance in 
congestive heart failure: demonstration in human subjects and verification in a paced 
canine model of ventricular failure." J Am Coll Cardiol 18(2): 464-472. 
 
Boscan, P., A. M. Allen and J. F. Paton (2001). "Baroreflex inhibition of cardiac 
sympathetic outflow is attenuated by angiotensin II in the nucleus of the solitary 
tract." Neuroscience 103(1): 153-160. 
 
Bouairi, E., R. Neff, C. Evans, A. Gold, M. C. Andresen and D. Mendelowitz (2004). 
"Respiratory sinus arrhythmia in freely moving and anesthetized rats." J Appl Physiol 
97(4): 1431-1436. 
 
Brignole, M., A. Auricchio, G. Baron-Esquivias, P. Bordachar, G. Boriani, O. A. 
Breithardt, J. Cleland, J. C. Deharo, V. Delgado, P. M. Elliott, B. Gorenek, C. W. 
Israel, C. Leclercq, C. Linde, L. Mont, L. Padeletti, R. Sutton, P. E. Vardas, J. L. 
Zamorano, S. Achenbach, H. Baumgartner, J. J. Bax, H. Bueno, V. Dean, C. Deaton, 
C. Erol, R. Fagard, R. Ferrari, D. Hasdai, A. W. Hoes, P. Kirchhof, J. Knuuti, P. Kolh, 
P. Lancellotti, A. Linhart, P. Nihoyannopoulos, M. F. Piepoli, P. Ponikowski, P. A. 
Sirnes, J. L. Tamargo, M. Tendera, A. Torbicki, W. Wijns, S. Windecker, C. 
Blomstrom-Lundqvist, L. P. Badano, F. Aliyev, D. Bänsch, W. Bsata, P. Buser, P. 
28 
 
Charron, J. C. Daubert, D. Dobreanu, S. Faerestrand, J. Y. Le Heuzey, H. Mavrakis, 
T. McDonagh, J. L. Merino, M. M. Nawar, J. C. Nielsen, B. Pieske, L. Poposka, F. 
Ruschitzka, I. C. Van Gelder, C. M. Wilson, E. C. f. P. G. (CPG) and D. Reviewers 
(2013). "2013 ESC Guidelines on cardiac pacing and cardiac resynchronization 
therapy: the Task Force on cardiac pacing and resynchronization therapy of the 
European Society of Cardiology (ESC). Developed in collaboration with the 
European Heart Rhythm Association (EHRA)." Eur Heart J 34(29): 2281-2329. 
Cleutjens, J. P., W. M. Blankesteijn, M. J. Daemen and J. F. Smits (1999). "The 
infarcted myocardium: simply dead tissue, or a lively target for therapeutic 
interventions." Cardiovasc Res 44(2): 232-241. 
 
Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences, Lawrence 
Erlbaum Associates. 
 
Coman, J., R. Freedman, B. A. Koplan, R. Reeves, P. Santucci, K. Q. Stolen, S. M. 
Kraus, T. E. Meyer and L. S. Results (2008). "A blended sensor restores 
chronotropic response more favorably than an accelerometer alone in pacemaker 
patients: the LIFE study results." Pacing Clin Electrophysiol 31(11): 1433-1442. 
 
Dandel, M., H. Lehmkuhl, C. Knosalla, N. Suramelashvili and R. Hetzer (2009). 
"Strain and strain rate imaging by echocardiography - basic concepts and clinical 
applicability." Curr Cardiol Rev 5(2): 133-148. 
 
Eckberg, D. L. (1983). "Human sinus arrhythmia as an index of vagal cardiac 
outflow." J Appl Physiol Respir Environ Exerc Physiol 54(4): 961-966. 
 
Edwards, S. J., C. Karner, N. Trevor, V. Wakefield and F. Salih (2015). "Dual-
chamber pacemakers for treating symptomatic bradycardia due to sick sinus 
syndrome without atrioventricular block: a systematic review and economic 
evaluation." Health Technol Assess 19(65): 1-210. 
 
Eldadah, Z. A., B. Rosen, I. Hay, T. Edvardsen, V. Jayam, T. Dickfeld, G. R. 
Meininger, D. P. Judge, J. Hare, J. B. Lima, H. Calkins and R. D. Berger (2006). 
"The benefit of upgrading chronically right ventricle-paced heart failure patients to 
resynchronization therapy demonstrated by strain rate imaging." Heart Rhythm 3(4): 
435-442. 
 
Elstad, M. (2012). "Respiratory variations in pulmonary and systemic blood flow in 
healthy humans." Acta Physiol (Oxf) 205(3): 341-348. 
 
Elstad, M., E. L. O'Callaghan, A. J. Smith, A. Ben-Tal and R. Ramchandra (2018). 
"Cardiorespiratory interactions in humans and animals: Rhythms for life." Am J 
Physiol Heart Circ Physiol. 
 
Feigl, E. O. (1983). "Coronary physiology." Physiol Rev 63(1): 1-205. 
 
Frampton, J. E., C. H. Orchard and M. R. Boyett (1991). "Diastolic, systolic and 
sarcoplasmic reticulum [Ca2+] during inotropic interventions in isolated rat 
myocytes." J Physiol 437: 351-375. 
29 
 
Francis, J., R. M. Weiss, S. G. Wei, A. K. Johnson and R. B. Felder (2001). 
"Progression of heart failure after myocardial infarction in the rat." Am J Physiol 
Regul Integr Comp Physiol 281(5): R1734-1745. 
 
Giardino, N. D., R. W. Glenny, S. Borson and L. Chan (2003). "Respiratory sinus 
arrhythmia is associated with efficiency of pulmonary gas exchange in healthy 
humans." Am J Physiol Heart Circ Physiol 284(5): H1585-1591. 
 
Goldman, S. and T. E. Raya (1995). "Rat infarct model of myocardial infarction and 
heart failure." J Card Fail 1(2): 169-177. 
 
Grossman, P. and E. W. Taylor (2007). "Toward understanding respiratory sinus 
arrhythmia: relations to cardiac vagal tone, evolution and biobehavioral functions." 
Biol Psychol 74(2): 263-285. 
 
Grossman, W., L. P. McLaurin, S. P. Moos, M. Stefadouros and D. T. Young (1974). 
"Wall thickness and diastolic properties of the left ventricle." Circulation 49(1): 129-
135. 
 
Hayano, J., F. Yasuma, A. Okada, S. Mukai and T. Fujinami (1996). "Respiratory 
sinus arrhythmia. A phenomenon improving pulmonary gas exchange and circulatory 
efficiency." Circulation 94(4): 842-847. 
 
Khurshid, S., A. E. Epstein, R. J. Verdino, D. Lin, L. R. Goldberg, F. E. Marchlinski 
and D. S. Frankel (2014). "Incidence and predictors of right ventricular pacing-
induced cardiomyopathy." Heart Rhythm 11(9): 1619-1625. 
 
Khurshid, S., E. Obeng-Gyimah, G. E. Supple, R. Schaller, D. Lin, A. T. Owens, A. 
E. Epstein, S. Dixit, F. E. Marchlinski and D. S. Frankel (2018). "Reversal of Pacing-
Induced Cardiomyopathy Following Cardiac Resynchronization Therapy." JACC Clin 
Electrophysiol 4(2): 168-177. 
 
Kirk, J. A., K. Chakir, K. H. Lee, E. Karst, R. J. Holewinski, G. Pironti, R. S. Tunin, I. 
Pozios, T. P. Abraham, P. de Tombe, H. A. Rockman, J. E. Van Eyk, R. Craig, T. G. 
Farazi and D. A. Kass (2015). "Pacemaker-induced transient asynchrony suppresses 
heart failure progression." Sci Transl Med 7(319): 319ra207. 
 
Kirk, J. A. and D. A. Kass (2013). "Electromechanical dyssynchrony and 
resynchronization of the failing heart." Circ Res 113(6): 765-776. 
 
Kovács, A., A. Oláh, Á. Lux, C. Mátyás, B. T. Németh, D. Kellermayer, M. Ruppert, 
M. Török, L. Szabó, A. Meltzer, A. Assabiny, E. Birtalan, B. Merkely and T. Radovits 
(2015). "Strain and strain rate by speckle-tracking echocardiography correlate with 
pressure-volume loop-derived contractility indices in a rat model of athlete's heart." 
Am J Physiol Heart Circ Physiol 308(7): H743-748. 
 
La Rovere, M. T., J. T. Bigger, Jr., F. I. Marcus, A. Mortara and P. J. Schwartz 
(1998). "Baroreflex sensitivity and heart-rate variability in prediction of total cardiac 
mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After 
Myocardial Infarction) Investigators." Lancet 351(9101): 478-484. 
30 
 
 
Lang, R. M., M. Bierig, R. B. Devereux, F. A. Flachskampf, E. Foster, P. A. Pellikka, 
M. H. Picard, M. J. Roman, J. Seward, J. S. Shanewise, S. D. Solomon, K. T. 
Spencer, M. S. Sutton, W. J. Stewart, C. Q. W. Group, A. S. o. E. s. G. a. S. 
Committee and E. A. o. Echocardiography (2005). "Recommendations for chamber 
quantification: a report from the American Society of Echocardiography's Guidelines 
and Standards Committee and the Chamber Quantification Writing Group, 
developed in conjunction with the European Association of Echocardiography, a 
branch of the European Society of Cardiology." J Am Soc Echocardiogr 18(12): 
1440-1463. 
 
Larsen, P. D., Y. C. Tzeng, P. Y. Sin and D. C. Galletly (2010). "Respiratory sinus 
arrhythmia in conscious humans during spontaneous respiration." Respir Physiol 
Neurobiol 174(1-2): 111-118. 
 
Leclercq, C., S. Cazeau, D. Lellouche, F. Fossati, F. Anselme, J. M. Davy, N. 
Sadoul, D. Klug, L. Mollo and J. C. Daubert (2007). "Upgrading from single chamber 
right ventricular to biventricular pacing in permanently paced patients with worsening 
heart failure: The RD-CHF Study." Pacing Clin Electrophysiol 30 Suppl 1: S23-30. 
 
McAllen, R. M. and K. M. Spyer (1978). "Two types of vagal preganglionic 
motoneurones projecting to the heart and lungs." J Physiol 282: 353-364. 
 
Milanez, M. C., M. G. Gomes, D. V. Vassallo and J. G. Mill (1997). "Effects of 
captopril on interstitial collagen in the myocardium after infarction in rats." J Card Fail 
3(3): 189-197. 
 
Mortara, A., M. T. La Rovere, M. G. Signorini, P. Pantaleo, G. Pinna, L. Martinelli, C. 
Ceconi, S. Cerutti and L. Tavazzi (1994). "Can power spectral analysis of heart rate 
variability identify a high risk subgroup of congestive heart failure patients with 
excessive sympathetic activation? A pilot study before and after heart 
transplantation." Br Heart J 71(5): 422-430. 
 
Mulder, P., S. Barbier, A. Chagraoui, V. Richard, J. P. Henry, F. Lallemand, S. 
Renet, G. Lerebours, F. Mahlberg-Gaudin and C. Thuillez (2004). "Long-term heart 
rate reduction induced by the selective I(f) current inhibitor ivabradine improves left 
ventricular function and intrinsic myocardial structure in congestive heart failure." 
Circulation 109(13): 1674-1679. 
 
Nogaret, A., L. Zhao, D. J. Moraes and J. F. Paton (2013). "Modulation of respiratory 
sinus arrhythmia in rats with central pattern generator hardware." J Neurosci 
Methods 212(1): 124-132. 
 
O'Callaghan, E. L., A. S. Chauhan, L. Zhao, R. M. Lataro, H. C. Salgado, A. Nogaret 
and J. F. Paton (2016). "Utility of a novel biofeedback device for within-breath 
modulation of heart rate in rats: a quantitative comparison of vagus nerve versus 
right atrial pacing." Frontiers in Physiology 7. 
 
31 
 
Pedrizzetti, G., J. Mangual and G. Tonti (2014). "On the geometrical relationship 
between global longitudinal strain and ejection fraction in the evaluation of cardiac 
contraction." J Biomech 47(3): 746-749. 
 
Pfeffer, M. A., J. M. Pfeffer, M. C. Fishbein, P. J. Fletcher, J. Spadaro, R. A. Kloner 
and E. Braunwald (1979). "Myocardial infarct size and ventricular function in rats." 
Circ Res 44(4): 503-512. 
 
Sin, P. Y., M. R. Webber, D. C. Galletly, P. N. Ainslie, S. J. Brown, C. K. Willie, A. 
Sasse, P. D. Larsen and Y. C. Tzeng (2010). "Interactions between heart rate 
variability and pulmonary gas exchange efficiency in humans." Exp Physiol 95(7): 
788-797. 
 
Spinale, F. G., R. Tanaka, F. A. Crawford and M. R. Zile (1992). "Changes in 
myocardial blood flow during development of and recovery from tachycardia-induced 
cardiomyopathy." Circulation 85(2): 717-729. 
 
Stein, A. B., S. Tiwari, P. Thomas, G. Hunt, C. Levent, M. F. Stoddard, X. L. Tang, R. 
Bolli and B. Dawn (2007). "Effects of anesthesia on echocardiographic assessment 
of left ventricular structure and function in rats." Basic Res Cardiol 102(1): 28-41. 
 
Sweeney, M. O. and A. S. Hellkamp (2006). "Heart failure during cardiac pacing." 
Circulation 113(17): 2082-2088. 
 
Taylor, E. W. (1994). "The evolution of efferent vagal control of the heart in 
vertebrates." Cardioscience 5(3): 173-182. 
 
Torres, C. A. and P. M. Janssen (2011). "Contractile strength during variable heart 
duration is species and preload dependent." J Biomed Biotechnol 2011: 294204. 
 
Torres, C. A., K. D. Varian and P. M. Janssen (2008). "Variability in interbeat 
duration influences myocardial contractility in rat cardiac trabeculae." Open 
Cardiovasc Med J 2: 100-104. 
 
Waki, H., K. Katahira, J. W. Polson, S. Kasparov, D. Murphy and J. F. Paton (2006). 
"Automation of analysis of cardiovascular autonomic function from chronic 
measurements of arterial pressure in conscious rats." Exp Physiol 91(1): 201-213. 
 
Whittaker, P., R. A. Kloner, D. R. Boughner and J. G. Pickering (1994). "Quantitative 
assessment of myocardial collagen with picrosirius red staining and circularly 
polarized light." Basic Res Cardiol 89(5): 397-410. 
 
Yamada, S., D. K. Arrell, G. C. Kane, T. J. Nelson, C. M. Perez-Terzic, A. Behfar, S. 
Purushothaman, F. W. Prinzen, A. Auricchio and A. Terzic (2013). "Mechanical 
dyssynchrony precedes QRS widening in ATP-sensitive K⁺ channel-deficient dilated 
cardiomyopathy." J Am Heart Assoc 2(6): e000410. 
 
32 
 
 Table 1: Cardiac function determined by non-invasive echocardiography before and after 2 weeks of treatment with the 
specified 
cardiac 
pacing.  
 
 
 
 
 
 
 
 
 
 
Unpaced Monotonic RMH 
 
Before After Before After Before After 
Weight (g) 301 ± 8 329 ± 10 296 ± 13 326 ± 12 303 ± 6 334 ± 8 
CO (mL.min-1) 116 ± 8 123 ± 5 118 ± 11 114 ± 11 114 ± 12 135 ± 12* 
HR (bpm) 406 ± 8 407 ± 9 375 ± 11 381 ± 10 415 ± 6 411 ± 9 
EF (%) 38 ± 4 40 ± 3 36 ± 2 33 ± 4 44 ± 4 47 ± 4 
SV (mL) 287 ± 20 304 ± 14 312 ± 21 297 ± 26 276 ± 24 335 ± 20* 
FS (%) 9 ± 3 12 ± 4 10 ± 1 10 ± 2 12 ± 2 14 ± 3 
FAC (%) 32 ± 12 33 ± 12 28 ± 2 26 ± 2 36 ± 3 37 ± 4 
LVEDV (mL) 768 ± 44 793 ± 67 863 ± 58 925 ± 104 649 ± 34 727 ± 42 
LVESV (mL) 481 ± 53 490 ± 63 551 ± 46 628 ± 105 373 ± 39 392 ± 54 
Cardiac index 
(mL.min-1.kg-1) 
387 ± 24 375 ± 10 396 ± 31 349 ± 33* 375 ± 25 415 ± 30 
SV index 
(mL.kg-1) 
954 ± 63 922 ± 20 1053 ± 66 916 ± 84* 906 ± 67 1009 ± 69 
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Abbreviations: CO, cardiac output; EF, ejection fraction; FAC, fractional area contraction; FS, fractional shortening; HR, heart rate; 
LVEDV, left ventricle end-diastolic volume; LVESV, left ventricle end-systolic volume; SV, stroke volume. 
* P<0.05 compared to before treatment, paired student’s t test. 
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Table 2: Results of ANCOVA test of measured cardiac variables testing for the interaction of baseline values with change 
from baseline for RMH- versus monotonic paced rats. Results of the Bonferroni t-test for multiple pairwise comparisons are also 
shown where appropriate. Abbreviations: see Table 1 and, CI, cardiac index; EDV, end diastolic volume; ESV, end systolic volume 
cardiac output; SVI, stroke volume index. 
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 ANCOVA   
Variable Interaction  
(baseline x Group 
change) 
Treatment difference of 
adjusted means   
Covariate as source of 
variation? P-value (Y/N) 
ANOVA 
(group sig) 
Bonferroni t-
test1 
CO P = 0.270 P = 0.045 P = 0.066 (N) P = 0.043 P = 0.040 
SV P = 0.369 P = 0.122 P = 0.025 (Y) n/a n/a 
EF P = 0.244 P = 0.079 P = 0.502 (N) P = 0.079 P = 0.093 
FAC P = 0.685 P = 0.094 P = 0.184 (N) P = 0.069 P = 0.215  
(P = 0.090^) 
FS P = 0.286 P = 0.658 P = 0.626 (N)  -  -  
EDV P = 0.347 P = 0.553 P = 0.347 (N) - - 
ESV P = 0.058 P = 0.697 P = 0.168 (N) - - 
HR P = 0.688 P = 0.927 P = 0.163 (N) - - 
CI P = 0.084 P = 0.079 P = 0.052 (N) P = 0.052 P = 0.050 
 
SVI 
P = 0.069 P = 0.213 P = 0.022 (Y) n/a n/a 
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Figures 
Figure 1  Experimental setup and representative example of HR waveforms 
during monotonic- and RMH- pacing 
Heart failure rats with surgically implanted right atrial pacing and dEMG recording 
electrodes were tethered within their cages and connected to the custom-built device 
(A).  The dEMG signal, consisting of bursts of activity during inspiration, was the 
bioelectric input to the device.  The signal was amplified, integrated and processed 
by the device to generate a spiking electrical output that increased in frequency 
during inspiration.  This device output was connected to the right atrial pacing leads 
to control the rat’s heart rate.  (B)  Representative example of transverse cardiac 
sections from a heart failure rat stained with Masson’s Trichome for infarct 
quantification. (C) A representative example from a rat being continuously paced by 
the device.  The bottom channel shows dEMG bursts of activity that drive the device 
spike output and produce fluctuations in the instantaneous frequency of the device 
output (device-HR).  The rat’s ECG is recorded simultaneously and the rat’s HR, 
calculated from the R-R interval is shown in red and perfectly matches the device-
HR during effective pacing. An expanded segment (inset panel) shows that peak-HR 
occurs during inspiration, consistent with the published pattern of intrinsic RSA 
(Bouairi, Neff et al. 2004). A green line in the device-HR channel represents 
average-HR matched monotonic pacing.  (D)  The ECG waveform channel was used 
to calculate the latency of the rat’s R-wave after the device (or monotonic) stimulus 
artefact was calculated for every stimulus spike and used to generate a post-
stimulus triggered histogram of each day’s pacing (bottom panel).     
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Figure 2  Changes in cardiac function after 2 weeks of monotonic or RMH 
pacing 
Cardiac output (and cardiac index) (A) and stroke volume (and stroke index) (B) 
increased significantly more in heart failure rats that underwent 2 weeks of RMH 
pacing compared to monotonic pacing, but not time-matched unpaced rats.  Two 
weeks of RMH-pacing tended to increase cardiac output and monotonic pacing 
significantly decreased cardiac- and stroke-indices when compared to null effect.  
Heart rate (C), ejection fraction (D), end-diastolic and end-systolic left ventricular 
volume (E) did not change significantly over the 2-week pacing (and unpaced) period 
in any groups.  The effect size for each treatment and variable are given below the x-
axis. 
Data are mean ± SEM. * P < 0.05 RMH compared to monotonic group (Unpaired t-
test), # P < 0.05 compared to null effect (One-sample t test).  P value is for 
comparisons to null effect. 
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Figure 3  Change in regional, endocardial strain (systolic function) after 2 
weeks of monotonic or RMH pacing 
(A) A representative example of a parasternal LV short axis, middle view with the 
endo- and epi-cardial walls outlined and divided into the 6 myocardial wall segments 
used in strain analysis, labelled in the adjacent schematic. (B) Representative 
example of radial (top) and circumferential (bottom) strain over a cardiac cycle.  The 
coloured traces indicate the magnitude of radial or circumferential strain as a 
continuum of time and 6 locations along the endocardial wall (C) The relative 
changes in myocardial radial and circumferential peak strain, averaged over regions 
1-4 of the endocardial wall are shown for each pacing treatment group.  
Data are mean ± SEM. * is P < 0.05 for comparisons before treatment data. 
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Figure 4 Cardiac synchrony after 2 weeks of monotonic or RMH pacing 
Representative examples of peak strain traces for 6 cardiac segments overlaying M-
mode view of parasternal LV long axis are shown and were used to calculate the 
standard deviation of time-to-peak (TTP) strain as a measure of cardiac 
dyssynchrony.  Examples are taken at the end of 2 weeks unpaced (A), 
monotonically-paced (B) and RMH-paced (C).  The grouped data of the change in 
dyssynchrony for each treatment is shown (D).  The change in myocardial radial and 
longitudinal peak strain (E) and peak strain rate (F) from the parasternal long axis 
view are shown for each pacing treatment group.   
 
Data are mean ± SEM.  
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Figure 5  Change in diastolic function after 2 weeks of monotonic or RMH 
pacing 
A) Echocardiographic analysis of LV posterior wall thickness (PW) relative to pre-
pacing period.  B) No significant change in LVPW thickness was observed in any 
group (One-sample T test compared to null effect).  C) Representative example of a 
transverse cardiac section stained with picrosirius red, viewed under bright light 
microscopy and a sample location used for collagen quantification inset, viewed 
under polarised light. D) Collagen infiltration following 2 weeks of pacing was not 
different between treatment groups.   
Data are mean ± SEM. * is P < 0.05 for comparisons between treatments (Unpaired t 
test) 
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Figure 6  The effects of RSA on coronary flow and LV contractility in the 
isolated perfused heart preparation. 
Representative recordings from the Langendorff heart preparation during baseline, 
simulated RMH and monotonic pacing are shown in A.  Heart slices stained with 
Evans’ blue after left coronary artery ligation are shown in B. The heart cross-
sections have a non-infarcted blue-marked area contrasting with an infarction area 
that did not absorb the dye.  Simulated RMH and monotonic sinoatrial node pacing 
increases coronary blood flow (C), LV contractility (+dP/dt) (D), and LV relaxation (E) 
after MI.  
Data are mean ± SEM. * p<0.05 compared to basal value within treatment groups 
(Paired t-test). 
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